Do the endocrine and subjective effects of d-fenfluramine predict response to selective serotonin reuptake inhibitors?
Thirty drug-free depressed patients underwent double-blind, placebo-controlled, neuroendocrine testing with the serotonin (5-HT) releasing agent d-fenfluramine prior to receiving treatment with a selective serotonin reuptake inhibitor (SSRI) for 8 weeks. Compared to placebo, d-fenfluramine significa...
主要な著者: | Park, S, Williamson, D, Cowen, P |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
1995
|
類似資料
-
Selective serotonin reuptake inhibitors
出版事項: (2004) -
Selective serotonin reuptake inhibitors.
著者:: Geddes, J, 等
出版事項: (2004) -
Effectiveness of selective serotonin reuptake inhibitors - Response
著者:: Barbui, C, 等
出版事項: (2008) -
Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
著者:: Chad Compagner, 等
出版事項: (2021-01-01) -
Ritanserin attenuates anorectic, endocrine and thermic responses to d-fenfluramine in human volunteers.
著者:: Goodall, E, 等
出版事項: (1993)